Mode
Text Size
Log in / Sign up
Phase 4 Completed N=47 Diagnostic

Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

Hepatic Disease
Source: ClinicalTrials.gov NCT03652636 ↗
Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Accuracy of CEUS at Differentiating Focal Nodular Hyperplasia (FNH) From Hepatocellular Adenoma (HCA) — 66.7; 64.0; 71.9; 90.6 percentage of lesions
◆ Published Evidence
Emerging
3citations · ~2 / year
Contrast-Enhanced Ultrasound Compared With Hepatobiliary Agent MRI for Differentiation of Focal Nodular Hyperplasia and Hepatic Adenoma: A Prospective Trial.
Ultrasound quarterly · 2024 · Likely link

Summary

In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.

Linked Publications

  • Contrast-Enhanced Ultrasound Compared With Hepatobiliary Agent MRI for Differentiation of Focal Nodular Hyperplasia and Hepatic Adenoma: A Prospective Trial.
    Ultrasound quarterly · 2024 · 3 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Accuracy of CEUS at Differentiating Focal Nodular Hyperplasia (FNH) From Hepatocellular Adenoma (HCA)
66.7; 64.0; 71.9; 90.6; 69.5; 78.0
SECONDARY
AUC of Differentiating FNH From HCA (AUC Represents the Probability That the Model, if Given a Randomly Chosen Correct and Incorrect CEUS Diagnosis of a Lesion, Will Rank the Correct Higher Than the Incorrect)
0.693; 0.768

Eligibility Criteria

Inclusion Criteria

  • Males and females
  • Age 18 years or greater
  • Scheduled to undergo abdominal MRI with contrast at a performance site for evaluation of a hepatic lesion(s).

Exclusion criteria

  • History of cardiac shunting
  • History of acute cardiac ischemia
  • History of hypersensitivity reaction to Lumason
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03652636) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search